United Therapeutics (UTHR) Treasury Shares (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Treasury Shares data on file, last reported at $5.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 56.62% year-over-year to $5.4 billion; the trailing twelve-month figure through Mar 2026 stood at $5.4 billion (up 56.62% YoY), and the FY2025 full-year result was $4.3 billion, up 22.62% from the prior year.
• Treasury Shares rose to $5.4 billion in Q1 2026, from $4.3 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $35.0 million in Q1 2026 to a low of $1.2 million in Q4 2024.
• A 5-year average of $25.5 million and a median of $26.6 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares changed 0.0% in 2022 and soared 56.62% in 2026, its largest moves.
• Tracing UTHR's Treasury Shares over 5 years: stood at $2.6 billion in 2022, then changed by 0.0% to $2.6 billion in 2023, then jumped by 34.71% to $3.5 billion in 2024, then gained by 22.62% to $4.3 billion in 2025, then grew by 27.73% to $5.4 billion in 2026.
• Business Quant data shows UTHR's Treasury Shares at $5.4 billion in Q1 2026, $4.3 billion in Q4 2025, and $4.3 billion in Q3 2025.